In the News
In the News
| Date | In The News | Topic |
|---|---|---|
| Dec 17, 2010 |
''Harkin, Bennet Applaud Dingell Drug Safety Bill'' "Washington, DC – Senate Health Education Labor and Pensions Committee Chairman Tom Harkin (D-IA) and Senator Michael Bennet (D-CO) today praised the introduction of U.S. Rep. John Dingell’s bill to protect consumers and American families by improving the safety and quality of pharmaceutical drugs."
|
Drug Manufacturing and Distribution, Drug Safety |
| Nov 26, 2010 |
''Drug Maker Cited on Quality Issues'' "Months after McNeil Consumer Healthcare, a unit of Johnson & Johnson, recalled millions of bottles of Tylenol and other over-the-counter drugs, the division is still plagued with manufacturing flaws, according to the Food and Drug Administration." |
Drug Manufacturing and Distribution, Drug Safety |
| Oct 26, 2010 |
''Glaxo to Pay $750 Million for Sale of Bad Products'' "GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant — the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines." |
Drug Manufacturing and Distribution, Drug Safety |
| Oct 19, 2010 |
''Musty odor sparks another Tylenol recall'' "A moldy odor has again stricken Johnson & Johnson's Tylenol, and the company is recalling another lot of the over-the-counter painkiller. J&J, which has recalled tens of millions of bottles of Tylenol and other consumer medicines in the past year because of complaints of a musty or moldy odor in the product, said it was voluntarily recalling another lot." |
Drug Manufacturing and Distribution, Drug Safety |
| Oct 14, 2010 |
''FDA Finds Heparin Maker Violations'' "A major U.S. heparin wholesaler received a complaint from a corporate customer about a contaminated batch of blood thinner in October 2008, but didn't investigate for almost a year, according to a recent Food and Drug Administration notice to the company." |
Drug Manufacturing and Distribution, Drug Safety |
| Oct 7, 2010 |
''Pfizer says recalled 191,000 Lipitor bottles'' "Pfizer Inc said it recalled 191,000 bottles of its top-selling Lipitor cholesterol fighter following reports of a musty odor coming from some bottles of the medicine made by a third-party supplier." |
Drug Manufacturing and Distribution, Drug Safety |
| Apr 29, 2010 |
''FDA Faulted in Heparin Case'' "The Food and Drug Administration failed to pursue several "specific and credible leads" that might have identified culprits in China during the 2008 crisis involving contaminated imported heparin, according to a congressional investigation." |
Drug Manufacturing and Distribution, Drug Safety |
| Apr 16, 2010 |
''New report stresses safety risks to Americans from Chinese-made pharmaceutical ingredients'' "A new report (pdf) by the U.S. China Economic and Security Review Commission stresses the safety risks to Americans posed by pharmaceutical ingredients made in China." |
Drug Manufacturing and Distribution, Drug Safety |
| Mar 18, 2010 |
''Report Says China Sold Bad Vaccines to Hospitals'' "A newspaper article by one of China’s best-known investigative reporters has reawakened a controversy over whether provincial authorities improperly stored vaccines in rooms without air-conditioning, rendering them ineffective, and then let them be administered to children." |
Drug Manufacturing and Distribution, Drug Safety |
| Sep 18, 2012 |
Prescription Painkillers: Misuse, Abuse, and Deaths Americans are dying in ever-increasing numbers from overdoses of opioid painkillers. Skyrocketing abuse of and dependence on prescription painkillers combined with growing sales has contributed to this increase in overdoses and deaths. |
Drug Safety |
| Aug 6, 2012 | "A new study suggests that using electronic health records to tell doctors what infections are going around in their community could help cut down on unnecessary antibiotic prescriptions." | Drug Safety, Antibiotic Innovation |
| Jan 5, 2012 |
''J&J, C.R. Bard Must Study Safety of Vaginal Mesh, FDA Says'' "Johnson & Johnson (JNJ) and C.R. Bard Inc. (BCR) must study rates of organ damage and complications linked to vaginal mesh implants, U.S. regulators said, responding to patient advocates who say the devices have harmed women." |
Drugs and Devices at the FDA |
| Jan 4, 2012 |
''F.D.A. Orders Surgical Mesh Makers to Study Risks'' "The Food and Drug Administration issued an order on Wednesday requiring makers of implantable surgical mesh used to treat urinary incontinence in women to study its risks." |
Drugs and Devices at the FDA |
| Dec 27, 2011 |
''The High Cost of Failing Artificial Hips'' "The most widespread medical implant failure in decades — involving thousands of all-metal artificial hips that need to be replaced prematurely — has entered the money phase." |
Drugs and Devices at the FDA |
| Dec 14, 2011 |
''Bill Would Require More Monitoring of Implants'' "Amid growing problems with artificial hips and other medical implants, bipartisan legislation was introduced in the Senate on Wednesday that would force manufacturers to track the performance of such products after they were approved for sale." |
Drugs and Devices at the FDA |
